JAKARTA (Yosefardi) – Largest pharmaceutical distributor in Indonesia, PT Enseval Putera Megatrading Tbk (EPMT) booked net profit of Rp464.37 billion in 2013, grew by 15% from Rp402.77 billion in 2012. Earning per share (EPS) was Rp171.
Sales rose 16.8% to Rp15.62 trillion from previous Rp13.37 trillion. Cost of goods sold also increased 16% to US$13.86 trillion from earlier Rp11.94 trillion.
Its assets grew by 11.6% to Rp5.53 trillion and liability increased 4.9% to Rp2.49 trillion. It has cash and cash equivalent of Rp405.18 billion.
Meanwhile, consumer company PT Tigaraksa Satria Tbk (TGKA) posted net profit of Rp133.86 billion last year, grew by 13.7% from Rp117.67 billion in 2012. EPS was Rp141.27.
Revenue increased 9% to Rp8.19 trillion from previous Rp7.49 trillion. Cost of goods sold rose 8.3% to Rp7.33 trillion. Its assets grew by 4.9% to Rp2.47 trillion while liability rose 3% to Rp1.83 trillion.